EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glutathione in HIV-Associated Neurocognitive Disorders

Thomas Erdos iD, Mika Masuda iD, Vishwanath Venketaraman iD

Current Issues in Molecular Biology · 31.05.2024 · 46 (6) · 5530-5549

DOI: 10.3390/cimb46060330 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 31.05.2024. Verfasst von Thomas Erdos und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH-NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A large portion of patients with Human Immunodeficiency Virus (HIV) have neurologic sequelae. Those with better-controlled HIV via antiretroviral therapies generally have less severe neurologic symptoms. However, for many patients, antiretrovirals do not adequately resolve symptoms. Since much of the pathogenesis of HIV/AIDS (Autoimmune Deficiency Syndrome) involves oxidative stress either directly, through viral interaction, or indirectly, through inflammatory mechanisms, we have reviewed relevant trials of glutathione supplementation in each of the HIV-associated neurocognitive diseases and have found disease-specific results. For diseases for which trials have not been completed, predicted responses to glutathione supplementation are made based on relevant mechanisms seen in the literature. It is not sufficient to conclude that all HIV-associated neurocognitive disorders (HAND) will benefit from the antioxidant effects of glutathione supplementation. The potential effects of glutathione supplementation in patients with HAND are likely to differ based on the specific HIV-associated neurocognitive disease.

Schlagwörter

Stichwörter der Autor:innen

AIDSHIVHIV-associated neurocognitive disorder (HAND)glutathioneneuroAIDS

Autor:innen und Institutionen

  • College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.

ORCID-Profile: Thomas Erdos, Mika Masuda, Vishwanath Venketaraman

Förderung

  • NHLBI NIH HHS
  • NIH-NHLBI

Zitieren

APA

Erdos, T., Masuda, M., & Venketaraman, V. (2024). Glutathione in HIV-Associated Neurocognitive Disorders. Current Issues in Molecular Biology, 46(6), 5530-5549. https://doi.org/10.3390/cimb46060330

Vancouver

Erdos T, Masuda M, Venketaraman V. Glutathione in HIV-Associated Neurocognitive Disorders. Current Issues in Molecular Biology. 2024;46(6):5530-5549. doi:10.3390/cimb46060330

BibTeX
@article{Erdos2024,
  author = {Erdos, Thomas and Masuda, Mika and Venketaraman, Vishwanath},
  title = {Glutathione in HIV-Associated Neurocognitive Disorders},
  journal = {Current Issues in Molecular Biology},
  year = {2024},
  volume = {46},
  number = {6},
  pages = {5530--5549},
  doi = {10.3390/cimb46060330}
}
Kostenlos starten →